Status:
COMPLETED
Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?
Lead Sponsor:
Charles University, Czech Republic
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Clopidogrel pre-treatment before planned percutaneous coronary intervention was proved to reduce periprocedural complications. However, the vast majority of patients in the current interventional card...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Elective CAG for suspected or proven coronary artery disease (stable forms or fully stabilized acute coronary syndrome)
- Signed written informed consent
Exclusion
- Thienopyridine treatment in previous two weeks
- Contraindication for clopidogrel
- CAG scheduled less than 6 hours after potential randomization
- Clinically significant bleeding (i.e. with hemoglobin fall by \> 50 g/l and/or requiring transfusions or surgery) in previous 3 months.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
July 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00432120
Start Date
March 1 2006
End Date
July 1 2007
Last Update
January 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles University
Prague, Czechia, 10034